论文部分内容阅读
近几年来,同时患有高血压和糖尿病的患者越来越多,厄贝沙坦和吡格列酮均为较有代表性的抗高血压和降糖药,由于这二种药物还具有延缓并发症及肾脏保护作用,故为此类患者较好的选择。目前采用高效液相色谱法测定人血浆中厄贝沙坦及吡格列酮的含量已有报道[1～4],而在同一临床样品
In recent years, more and more patients with hypertension and diabetes mellitus, irbesartan and pioglitazone are more representative of antihypertensive and hypoglycemic agents, as these two drugs also delay the complications and Kidney protection, it is a better choice for such patients. At present, the determination of irbesartan and pioglitazone in human plasma by HPLC has been reported [1 ~ 4], while in the same clinical sample